ApicHope Pharmaceutical Co., Ltd (300723.SZ)
CNY 20.27
(-2.55%)
CNY 20.27
(-2.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.5 Billion | 2.28 Billion | 2.19 Billion | 1.67 Billion | 1.63 Billion | 1.42 Billion |
| Cost of Revenue | 474.58 Million | 300.2 Million | 318.46 Million | 295.42 Million | 367.03 Million | 393.47 Million |
| Gross Profit | 2.02 Billion | 1.97 Billion | 1.88 Billion | 1.37 Billion | 1.27 Billion | 1.03 Billion |
| Operating Expenses | 1.81 Billion | 1.64 Billion | 1.6 Billion | 1.18 Billion | 1.04 Billion | 796.66 Million |
| Selling, General and Administrative Expenses | 1.42 Billion | 1.31 Billion | 1.33 Billion | 953.33 Million | 879.19 Million | 643.96 Million |
| Research and Development Expenses | 301.36 Million | 189.78 Million | 142.32 Million | 135.34 Million | 98.04 Million | 91.38 Million |
| Other Expenses | 88.27 Million | 31.97 Million | 101.44 Million | 74.74 Million | 6.78 Million | 8.87 Million |
| Cost and Expenses | 2.28 Billion | 1.94 Billion | 1.92 Billion | 1.47 Billion | 1.41 Billion | 1.19 Billion |
| Operating Income | 213.93 Million | 281.97 Million | 285.28 Million | 198.55 Million | 182.26 Million | 234.83 Million |
| Interest Expense | 37.65 Million | 24.45 Million | 38.5 Million | 11.74 Million | 5.38 Million | 17.4 Million |
| Income Tax Expense | 92.38 Million | 64.31 Million | 69.35 Million | 49.66 Million | 46.52 Million | 36.02 Million |
| Earnings before Tax | 244.18 Million | 326.41 Million | 362.77 Million | 273.29 Million | 189.05 Million | 243.7 Million |
| Net Income | 184.61 Million | 290.68 Million | 306.91 Million | 225.61 Million | 143.68 Million | 208.22 Million |
| Earnings Per Share Basic | 0.42 | 0.69 | 0.71 | 0.52 | 0.33 | 0.48 |
| Earnings Per Share Diluted | 0.42 | 0.69 | 0.71 | 0.52 | 0.33 | 0.48 |
| Weighted Average Shares Outstanding | 439.55 Million | 420.82 Million | 430.25 Million | 433.86 Million | 431.05 Million | 432 Million |
| Weighted Average Shares Outstanding (Diluted) | 439.55 Million | 420.82 Million | 430.25 Million | 433.86 Million | 431.05 Million | 435.81 Million |
| Gross Margin | 0.81 | 0.87 | 0.86 | 0.82 | 0.78 | 0.72 |
| EBIT Margin | 0.19 | 0.20 | 0.22 | 0.20 | 0.17 | 0.22 |
| Profit Margin | 0.07 | 0.13 | 0.14 | 0.13 | 0.09 | 0.15 |
| EBITDA | 464.04 Million | 448.31 Million | 498.78 Million | 326.84 Million | 232.62 Million | 297.28 Million |
| Earnings Before Tax Margin | 0.09 | 0.12 | 0.13 | 0.12 | 0.11 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 320.63 Million | 283.64 Million | 622.87 Million | 2.5 Billion | 653.63 Million | 584.09 Million |
| Cost of Revenue | 161.91 Million | 132.37 Million | 150.91 Million | 474.58 Million | 125.83 Million | 139.72 Million |
| Gross Profit | 158.71 Million | 151.26 Million | 471.95 Million | 2.02 Billion | 527.8 Million | 444.37 Million |
| Operating Expenses | 169.08 Million | 205.03 Million | 347 Million | 1.75 Billion | 539.64 Million | 342.92 Million |
| Selling, General and Administrative Expenses | 110.98 Million | 132.05 Million | 281.88 Million | - | 212.16 Million | 389.57 Million |
| Research and Development Expenses | 58.1 Million | 72.98 Million | 62.52 Million | - | 124.71 Million | 46.39 Million |
| Other Expenses | - | -3.13 Million | -2.49 Million | 30.25 Million | -12.11 Million | -995.55 Thousand |
| Cost and Expenses | 331 Million | 337.41 Million | 497.92 Million | 2.22 Billion | 665.47 Million | 482.65 Million |
| Operating Income | -10.37 Million | -53.76 Million | 114.18 Million | 213.93 Million | -54.85 Million | 101.49 Million |
| Interest Expense | 4.62 Million | 8.58 Million | 12.3 Million | 37.65 Million | 31.66 Million | -11.79 Million |
| Income Tax Expense | -2.38 Million | -9.48 Million | 16.2 Million | 92.38 Million | 40.58 Million | 31.31 Million |
| Earnings before Tax | -302.86 Million | -73.94 Million | 111.69 Million | 244.18 Million | -66.97 Million | 100.5 Million |
| Net Income | -292.99 Million | -54.05 Million | 100.51 Million | 184.61 Million | -97.33 Million | 77.01 Million |
| Earnings Per Share Basic | -0.65 | -0.12 | 0.22 | - | -0.25 | 0.17 |
| Earnings Per Share Diluted | -0.65 | -0.12 | 0.22 | - | -0.25 | 0.17 |
| Weighted Average Shares Outstanding | 451.66 Million | 454.14 Million | 454.18 Million | 439.55 Million | 395.69 Million | 446.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 451.66 Million | 454.14 Million | 454.18 Million | 439.55 Million | 395.69 Million | 446.61 Million |
| Gross Margin | 0.50 | 0.53 | 0.76 | 0.81 | 0.81 | 0.76 |
| EBIT Margin | -0.93 | 0.00 | 0.20 | - | -0.04 | 0.15 |
| Profit Margin | -0.91 | -0.19 | 0.16 | 0.07 | -0.15 | 0.13 |
| EBITDA | -298.23 Million | 313.77 Thousand | 124 Million | - | -28.45 Million | 88.79 Million |
| Earnings Before Tax Margin | -0.03 | -0.19 | 0.18 | 0.09 | -0.08 | 0.17 |
CFRESH
FARYF
AS
EPE
BCTCF
MODRNSH